Amgen has shared (PDF) the first phase 3 data on its $400 million eczema drug, linking the anti-OX40 antibody to significant improvements in symptoms. But, while the trial met its primary endpoints, ...
Amgen Inc. (NASDAQ:AMGN) is a global biotechnology company recognised for its focus on biologic medicines addressing serious ...
Amgen’s investigational monoclonal antibody paired with chemotherapy significantly improved overall survival for patients in a phase 3 stomach cancer trial compared to chemotherapy alone, according to ...
Zacks Investment Research on MSN
Investors heavily search Amgen Inc. (AMGN): Here is what you need to know
Amgen (AMGN) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...
After three decades spent rising through the ranks of sales and marketing teams at major pharmas, Chris Boulton is taking the ...
US biotech Amgen (Nasdaq: AMGN) has won approval from the US regulator for Uplizna (inebilizumab-cdon) to treat adults with ...
Amgen has transitioned into a mature, cash-generating pharma-biotech hybrid, offering defensive characteristics, capital preservation, and yield over high-growth potential. The diversified product ...
Zacks Investment Research on MSN
Amgen (AMGN) outpaces stock market gains: What you should know
In the latest close session, Amgen (AMGN) was up +1.22% at $331.39. The stock exceeded the S&P 500, which registered a gain of 0.64% for the day. Meanwhile, the Dow experienced a rise of 0.47%, and ...
HOLLY SPRINGS, N.C. (WTVD) -- A biotechnology company will expand its manufacturing operation in Holly Springs that will create jobs and invest a $1 billion in Wake County. Economists in the ...
We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against other best ...
LASEC and the Los Angeles World Cup 2026 Host Committee Will Collaborate with Amgen to Amplify Community Health and Legacy Programs in Greater Los Angeles Ahead of Historic Sporting Events LOS ANGELES ...
Recent negative sentiment mostly driven by political bashing of price gouging pharmaceutical companies have driven the prices down for pharma and biotech companies in general. Amgen relies heavily on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback